1 Study Coverage
    1.1 Peripheral Intervention Drug-Eluting Devices Product Introduction
    1.2 Market by Type
        1.2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Drug-Eluting Balloons
        1.2.3 Drug-Eluting Stents
    1.3 Market by Application
        1.3.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Plain Old Balloon Angioplasty (POBA)
        1.3.3 Percutaneous Transluminal Angioplasty (PTA)
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Estimates and Forecasts 2017-2028
    2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Estimates and Forecasts 2017-2028
    2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Peripheral Intervention Drug-Eluting Devices Sales by Region
        2.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2017-2022)
        2.4.2 Global Sales Peripheral Intervention Drug-Eluting Devices by Region (2023-2028)
    2.5 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region
        2.5.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2017-2022)
        2.5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturers
        3.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Sales (2017-2022)
        3.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peripheral Intervention Drug-Eluting Devices in 2021
    3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers
        3.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers (2017-2022)
        3.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Peripheral Intervention Drug-Eluting Devices Revenue in 2021
    3.3 Global Peripheral Intervention Drug-Eluting Devices Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Peripheral Intervention Drug-Eluting Devices Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type
        4.1.1 Global Peripheral Intervention Drug-Eluting Devices Historical Sales by Type (2017-2022)
        4.1.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Sales by Type (2023-2028)
        4.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2028)
    4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type
        4.2.1 Global Peripheral Intervention Drug-Eluting Devices Historical Revenue by Type (2017-2022)
        4.2.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2017-2028)
    4.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type
        4.3.1 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2017-2022)
        4.3.2 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Application
        5.1.1 Global Peripheral Intervention Drug-Eluting Devices Historical Sales by Application (2017-2022)
        5.1.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Sales by Application (2023-2028)
        5.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2028)
    5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application
        5.2.1 Global Peripheral Intervention Drug-Eluting Devices Historical Revenue by Application (2017-2022)
        5.2.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2017-2028)
    5.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application
        5.3.1 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2017-2022)
        5.3.2 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Peripheral Intervention Drug-Eluting Devices Market Size by Type
        6.1.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2028)
        6.1.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2028)
    6.2 North America Peripheral Intervention Drug-Eluting Devices Market Size by Application
        6.2.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2028)
        6.2.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2028)
    6.3 North America Peripheral Intervention Drug-Eluting Devices Market Size by Country
        6.3.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2028)
        6.3.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Type
        7.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2028)
        7.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2028)
    7.2 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Application
        7.2.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2028)
        7.2.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2028)
    7.3 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Country
        7.3.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2028)
        7.3.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Type
        8.1.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2028)
        8.1.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2028)
    8.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Application
        8.2.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2028)
        8.2.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2028)
    8.3 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Region
        8.3.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2017-2028)
        8.3.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Peripheral Intervention Drug-Eluting Devices Market Size by Type
        9.1.1 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2028)
        9.1.2 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2028)
    9.2 Latin America Peripheral Intervention Drug-Eluting Devices Market Size by Application
        9.2.1 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2028)
        9.2.2 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2028)
    9.3 Latin America Peripheral Intervention Drug-Eluting Devices Market Size by Country
        9.3.1 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2028)
        9.3.2 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size by Type
        10.1.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2028)
    10.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size by Application
        10.2.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2028)
    10.3 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size by Country
        10.3.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Medtronic plc
        11.1.1 Medtronic plc Corporation Information
        11.1.2 Medtronic plc Overview
        11.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Medtronic plc Recent Developments
    11.2 Boston Scientific Corporation
        11.2.1 Boston Scientific Corporation Corporation Information
        11.2.2 Boston Scientific Corporation Overview
        11.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Boston Scientific Corporation Recent Developments
    11.3 Abbott Laboratories
        11.3.1 Abbott Laboratories Corporation Information
        11.3.2 Abbott Laboratories Overview
        11.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Abbott Laboratories Recent Developments
    11.4 Cardinal Health
        11.4.1 Cardinal Health Corporation Information
        11.4.2 Cardinal Health Overview
        11.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Cardinal Health Recent Developments
    11.5 B. Braun Melsungen AG
        11.5.1 B. Braun Melsungen AG Corporation Information
        11.5.2 B. Braun Melsungen AG Overview
        11.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 B. Braun Melsungen AG Recent Developments
    11.6 Biosensors International Group Ltd.
        11.6.1 Biosensors International Group Ltd. Corporation Information
        11.6.2 Biosensors International Group Ltd. Overview
        11.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Biosensors International Group Ltd. Recent Developments
    11.7 C.R. Bard, Inc.
        11.7.1 C.R. Bard, Inc. Corporation Information
        11.7.2 C.R. Bard, Inc. Overview
        11.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 C.R. Bard, Inc. Recent Developments
    11.8 Abbott
        11.8.1 Abbott Corporation Information
        11.8.2 Abbott Overview
        11.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Abbott Recent Developments
    11.9 The Lubrizol Corporation
        11.9.1 The Lubrizol Corporation Corporation Information
        11.9.2 The Lubrizol Corporation Overview
        11.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 The Lubrizol Corporation Recent Developments
    11.10 Terumo Corporation
        11.10.1 Terumo Corporation Corporation Information
        11.10.2 Terumo Corporation Overview
        11.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Terumo Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Peripheral Intervention Drug-Eluting Devices Industry Chain Analysis
    12.2 Peripheral Intervention Drug-Eluting Devices Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Peripheral Intervention Drug-Eluting Devices Production Mode & Process
    12.4 Peripheral Intervention Drug-Eluting Devices Sales and Marketing
        12.4.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
        12.4.2 Peripheral Intervention Drug-Eluting Devices Distributors
    12.5 Peripheral Intervention Drug-Eluting Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Peripheral Intervention Drug-Eluting Devices Industry Trends
    13.2 Peripheral Intervention Drug-Eluting Devices Market Drivers
    13.3 Peripheral Intervention Drug-Eluting Devices Market Challenges
    13.4 Peripheral Intervention Drug-Eluting Devices Market Restraints
14 Key Findings in The Global Peripheral Intervention Drug-Eluting Devices Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Drug-Eluting Balloons
    Table 3. Major Manufacturers of Drug-Eluting Stents
    Table 4. Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2017-2022) & (K Units)
    Table 7. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2017-2022)
    Table 8. Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2023-2028) & (K Units)
    Table 9. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2023-2028)
    Table 10. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2017-2022)
    Table 12. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2023-2028)
    Table 14. Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Manufacturers (2017-2022)
    Table 16. Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers (2017-2022)
    Table 18. Peripheral Intervention Drug-Eluting Devices Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Peripheral Intervention Drug-Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2021)
    Table 21. Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Peripheral Intervention Drug-Eluting Devices Product Offered
    Table 23. Date of Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
    Table 26. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
    Table 27. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2017-2022)
    Table 28. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2023-2028)
    Table 29. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2017-2022)
    Table 32. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2023-2028)
    Table 33. Peripheral Intervention Drug-Eluting Devices Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
    Table 36. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
    Table 37. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2017-2022)
    Table 38. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2023-2028)
    Table 39. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Application (2017-2022)
    Table 42. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Application (2023-2028)
    Table 43. Peripheral Intervention Drug-Eluting Devices Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
    Table 46. North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
    Table 47. North America Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Peripheral Intervention Drug-Eluting Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
    Table 50. North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
    Table 51. North America Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Peripheral Intervention Drug-Eluting Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2022) & (K Units)
    Table 54. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2023-2028) & (K Units)
    Table 55. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Medtronic plc Corporation Information
    Table 106. Medtronic plc Description and Major Businesses
    Table 107. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Medtronic plc Recent Developments
    Table 110. Boston Scientific Corporation Corporation Information
    Table 111. Boston Scientific Corporation Description and Major Businesses
    Table 112. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Boston Scientific Corporation Recent Developments
    Table 115. Abbott Laboratories Corporation Information
    Table 116. Abbott Laboratories Description and Major Businesses
    Table 117. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Abbott Laboratories Recent Developments
    Table 120. Cardinal Health Corporation Information
    Table 121. Cardinal Health Description and Major Businesses
    Table 122. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Cardinal Health Recent Developments
    Table 125. B. Braun Melsungen AG Corporation Information
    Table 126. B. Braun Melsungen AG Description and Major Businesses
    Table 127. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. B. Braun Melsungen AG Recent Developments
    Table 130. Biosensors International Group Ltd. Corporation Information
    Table 131. Biosensors International Group Ltd. Description and Major Businesses
    Table 132. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Biosensors International Group Ltd. Recent Developments
    Table 135. C.R. Bard, Inc. Corporation Information
    Table 136. C.R. Bard, Inc. Description and Major Businesses
    Table 137. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. C.R. Bard, Inc. Recent Developments
    Table 140. Abbott Corporation Information
    Table 141. Abbott Description and Major Businesses
    Table 142. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Abbott Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Abbott Recent Developments
    Table 145. The Lubrizol Corporation Corporation Information
    Table 146. The Lubrizol Corporation Description and Major Businesses
    Table 147. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. The Lubrizol Corporation Recent Developments
    Table 150. Terumo Corporation Corporation Information
    Table 151. Terumo Corporation Description and Major Businesses
    Table 152. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Terumo Corporation Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Peripheral Intervention Drug-Eluting Devices Distributors List
    Table 158. Peripheral Intervention Drug-Eluting Devices Customers List
    Table 159. Peripheral Intervention Drug-Eluting Devices Market Trends
    Table 160. Peripheral Intervention Drug-Eluting Devices Market Drivers
    Table 161. Peripheral Intervention Drug-Eluting Devices Market Challenges
    Table 162. Peripheral Intervention Drug-Eluting Devices Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Peripheral Intervention Drug-Eluting Devices Product Picture
    Figure 3. Global Peripheral Intervention Drug-Eluting Devices Market Share by Type in 2021 & 2028
    Figure 3. Drug-Eluting Balloons Product Picture
    Figure 4. Drug-Eluting Stents Product Picture
    Figure 5. Global Peripheral Intervention Drug-Eluting Devices Market Share by Application in 2021 & 2028
    Figure 6. Plain Old Balloon Angioplasty (POBA)
    Figure 7. Percutaneous Transluminal Angioplasty (PTA)
    Figure 8. Peripheral Intervention Drug-Eluting Devices Report Years Considered
    Figure 9. Global Peripheral Intervention Drug-Eluting Devices Sales 2017-2028 (K Units)
    Figure 10. Global Peripheral Intervention Drug-Eluting Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Peripheral Intervention Drug-Eluting Devices Revenue 2017-2028 (US$ Million)
    Figure 12. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2017-2022)
    Figure 14. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2023-2028)
    Figure 15. North America Peripheral Intervention Drug-Eluting Devices Sales YoY (2017-2028) & (K Units)
    Figure 16. North America Peripheral Intervention Drug-Eluting Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Peripheral Intervention Drug-Eluting Devices Sales YoY (2017-2028) & (K Units)
    Figure 18. Europe Peripheral Intervention Drug-Eluting Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales YoY (2017-2028) & (K Units)
    Figure 20. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Peripheral Intervention Drug-Eluting Devices Sales YoY (2017-2028) & (K Units)
    Figure 22. Latin America Peripheral Intervention Drug-Eluting Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales YoY (2017-2028) & (K Units)
    Figure 24. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Peripheral Intervention Drug-Eluting Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Peripheral Intervention Drug-Eluting Devices in the World: Market Share by Peripheral Intervention Drug-Eluting Devices Revenue in 2021
    Figure 27. Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2028)
    Figure 29. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2017-2028)
    Figure 30. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2028)
    Figure 31. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2017-2028)
    Figure 32. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2028)
    Figure 33. North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2017-2028)
    Figure 34. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2028)
    Figure 35. North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2017-2028)
    Figure 36. North America Peripheral Intervention Drug-Eluting Devices Sales Share by Country (2017-2028)
    Figure 37. North America Peripheral Intervention Drug-Eluting Devices Revenue Share by Country (2017-2028)
    Figure 38. U.S. Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2028)
    Figure 41. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2028)
    Figure 43. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Peripheral Intervention Drug-Eluting Devices Sales Share by Country (2017-2028)
    Figure 45. Europe Peripheral Intervention Drug-Eluting Devices Revenue Share by Country (2017-2028)
    Figure 46. Germany Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 47. France Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue Share by Region (2017-2028)
    Figure 57. China Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 60. India Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Peripheral Intervention Drug-Eluting Devices Sales Share by Country (2017-2028)
    Figure 72. Latin America Peripheral Intervention Drug-Eluting Devices Revenue Share by Country (2017-2028)
    Figure 73. Mexico Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Share by Country (2017-2028)
    Figure 82. Turkey Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 84. U.A.E Peripheral Intervention Drug-Eluting Devices Revenue (2017-2028) & (US$ Million)
    Figure 85. Peripheral Intervention Drug-Eluting Devices Value Chain
    Figure 86. Peripheral Intervention Drug-Eluting Devices Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed